Antioxidant Nutrients and Prevention of Oxidant-Mediated, Smoking-Related Diseases

  • Ronald Anderson
Part of the Nutrition ◊ and ◊ Health book series (NH)


Certain high-risk occupations, adverse socioeconomic and sociocultural circumstances, and unhealthy, avoidable aspects of lifestyle may, individually or collectively, result in heightened levels of oxidative stress, predisposing the individual to future development of oxidant-mediated organ dysfunction and disease (1,2). Outdated and/or poorly regulated industrial practices, unacceptably high levels of vehicle exhaust emissions, overpopulation associated with overcrowded, poorly ventilated, nonelectrified dwellings and poor dispersal of atmospheric pollutants because of unfavorable climatic conditions and/or topography are problems commonly encountered in, but not limited to, many developing countries (3,4). In these circumstances, chronic exposure to excessive levels of atmospheric pollution in the workplace, environment, and home is accompanied by increased oxidative stress. Unhealthy lifestyles, such as poor dietary habits, especially low intake of fresh fruits and vegetables (5), cigarette smoking (2), and in some cases excessive exposure to ultraviolet radiation (6), also accelerate the onset of those degenerative diseases (cataracts, cardiovascular diseases, cancer, pulmonary dysfunction, and emphysema), which have a suspected oxidant-mediated etiology (1,2).


Cigarette Smoking Plasma Vitamin Pulmonary Dysfunction Antioxidant Nutrient Oxidative Inactivation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fulton M, Thomson M, Elton RA, Brown S, Wood DA, Oliver MF Cigarette smoking, social class and nutrient intake: relevance to coronary heart disease. Eur J Clin Nutr 1988; 42:797–803.Google Scholar
  2. 2.
    Pryor WA, Stone K. Oxidants in cigarette smoke. Ann NY Acad Sci 1993; 686:12–28.CrossRefGoogle Scholar
  3. 3.
    Godlee R. Air pollution I. From pea soup to photochemical smog. Br Med J 1991; 303:1459–1461.CrossRefGoogle Scholar
  4. 4.
    Melia RJ, Florey C de V, Altman DG, Swan AV. Association between gas cooking and respiratory disease in children. Br Med J 1977; 2:149–152.CrossRefGoogle Scholar
  5. 5.
    Block G. Micronutrients and cancer: time for action? J Nail Cancer Inst USA 1993; 85:846–848.CrossRefGoogle Scholar
  6. 6.
    Savage JE, Theron AJ, Anderson R. Activation of neutrophil membrane-associated oxidative metabolism by ultraviolet radiation. J Invest Dermatol 1993; 101:532–536.CrossRefGoogle Scholar
  7. 7.
    Peto R. Smoking and death: the past 40 years and the next 40. Br Med J 1994; 309:937–939. 8. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. Br Med J 1994; 309:901–911.Google Scholar
  8. 9.
    Corré F, Lellouch J, Schwartz D. Smoking and leucocyte counts. Lancet 1971; 2:632–634.Google Scholar
  9. 10.
    Hoidal JR, Niewoehner DE. Lung Phagocyte recruitment and metabolic deterioration induced by cigarette smoke in humans and hamsters. Am Rev Resp Dis 1982; 126:548–552.Google Scholar
  10. 11.
    Anderson R, Rabson AR, Sher R, Koornhof HJ. The NBT test in cigarette smokers. Am J Clin Pathol 1974; 61:879.Google Scholar
  11. 12.
    Hoidal JR, Fox RB, Lemarbe PA, Perri R, Repine JE. Altered oxidative metabolic responses in vivo of alveolar macrophages from asymptomatic cigarette smokers. Am Rev Respir Dis 1981; 123:85–87.Google Scholar
  12. 13.
    Wright JL, Hobson JE, Wiggs B, Pare PD, Hogg JC. Airway inflammation and peribronchiolar attachments in the lungs of non-smokers, current and ex-smokers. Lung 1988; 166:277–286.CrossRefGoogle Scholar
  13. 14.
    Ludwig PW, Schwartz BA, Hoidal JR, Niewoehner DE. Cigarette smoking causes accumulation of polymorphonuclear leukocytes in alveolar septum. Am Rev Respir Dis 1985; 131:828–830.Google Scholar
  14. 15.
    Chan-Yeung M, Dy Buncio A. Leukocyte count, smoking and lung function. Am J Med 1984; 76:31–37.CrossRefGoogle Scholar
  15. 16.
    Chan-Yeung M, Abbound R, Dy Buncio A, Vedal S. Peripheral leukocyte count and longitudinal decline in lung function. Thorax 1988; 43:462–466.CrossRefGoogle Scholar
  16. 17.
    Sparrow D, Glynn Ri, Cohen M, Weiss ST. The relationship of the peripheral leukocyte count and cigarette smoking to pulmonary function among adult men. Chest 1984; 86:383–386.CrossRefGoogle Scholar
  17. 18.
    Ludwig RW, Hoidal JR. Alterations in leukocyte oxidative metabolism in cigarette smokers. Am Rev Respir Dis 1982; 126:977–980.Google Scholar
  18. 19.
    Bridges RB, Fu MC, Rehm SR. Increased neutrophil myeloperoxidase activity associated with cigarette smoking. Eur J Resp Dis 1985; 67:84–93.Google Scholar
  19. 20.
    Richards GA, Theron AJ, Van der Merwe CA, Anderson R. Spirometric abnormalities in young smokers correlate with increased chemiluminescence responses of activated blood phagocytes. Am Rev Respir Dis 1989; 139:181–187.CrossRefGoogle Scholar
  20. 21.
    MacNee W, Wiggs B, Belzberb AS, Hogg JC. The effect of cigarette smoking on neutrophil kinetics in human lungs. New Engl J Med 1989; 321:924–928.CrossRefGoogle Scholar
  21. 22.
    Bosken CH, Doerschuk CM, English D, Hogg JC. Neutrophil kinetics during active cigarette smoking in rabbits. JAppl Physiol 1991; 71:630–637.Google Scholar
  22. 23.
    Lehr H-A, Frei B, Arfors KE. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci USA 1994; 91:7688–7692.CrossRefGoogle Scholar
  23. 24.
    Lehr H-A, Kress E, Menger MD, et al. Cigarette smoke elicits leukocyte adhesion to endothelium in hamsters: inhibition by Cu-Zn SOD. Free Radic Biol Med 1993; 14:573–581.CrossRefGoogle Scholar
  24. 25.
    Klut ME, Doerschuk CM, Van Eeden SF, Bums AR, Hogg JC. Activation of neutrophils within pulmonary microvessels of rabbits exposed to cigarette smoke. Am J Resp Cell Mol Biol 1993; 9:82–89.Google Scholar
  25. 26.
    Bridges AB, Hill A, Belch JJF. Cigarette smoking increases white blood cell aggregation in whole blood. J Royal Soc Med 1993; 86:139–141.Google Scholar
  26. 27.
    Hind CRK, Joyce H, Tennent GA, Pepys MB, Pride NB. Plasma leucocyte elastase concentrations in smokers. J Clin Pathol 1991; 44:232–235.CrossRefGoogle Scholar
  27. 28.
    Babior BM. Oxidants from phagocytes: agents of defense and destruction. Blood 1984; 64:959–964.Google Scholar
  28. 29.
    Leanderson P. Cigarette smoke-induced DNA damage in cultured human lung cells. Ann NY Acad Sci 1993; 686:249–261.CrossRefGoogle Scholar
  29. 30.
    Borish ET, Cosgrove JP, Church DF, Deutsch WA, Pryor WA. Cigarette tar causes single strand breaks in DNA. Biochem Biophys Res Comm 1985; 133:780–786.CrossRefGoogle Scholar
  30. 31.
    Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 1990; 76:655–663.Google Scholar
  31. 32.
    Jackson JH, Gajewski E, Schraufstatter U, et al. Damage to the bases in DNA induced by stimulated human neutrophils. J Clin Invest 1989; 84:1644 1649.Google Scholar
  32. 33.
    Van Rensburg CEJ, Van Staden AM, Anderson R. Inactivation of poly(ADP-ribose)polymerase by hypochlorous acid. Free Radic Biol Med 1991; 11:285–291.CrossRefGoogle Scholar
  33. 34.
    Weiss SJ. Tissue destruction by neutrophils. New Engl J Med 1989; 320:365–376.CrossRefGoogle Scholar
  34. 35.
    Desrochers PE, Mookhtiar K, Van Wart HE, Hasty KA, Weiss SJ. Proteolytic inactivation of α1-proteinase inhibitor and α1-chymotrypsin by oxidatively activated human neutrophil metalloproteinases. J Biol Chem 1992; 267: 5005–5012.Google Scholar
  35. 36.
    Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344:793–795.CrossRefGoogle Scholar
  36. 37.
    Lopes-Virella MF, Virella G. Atherosclerosis and autoimmunity. Clin Immunol Immunopathol 1994; 73:155–167.CrossRefGoogle Scholar
  37. 38.
    Cross CE, O’Neill CA, Reznick AZ, et al. Cigarette smoke oxidation of human plasma constituents. Ann NYAcad Sci 1993; 686:72–90.CrossRefGoogle Scholar
  38. 39.
    El-Hag A, Lipsky PE, Bennett M, Clark RA. Immunomodulation by neutrophil meyloperoxidase and hydrogen peroxide: differential susceptibility of human lymphocyte functions. J Immunol 1987; 139:2406–2413.Google Scholar
  39. 40.
    Anderson R, Smit MJ, Jooné GK, Van Staden AM. Vitamin C and cellular immune functions: protection against hypochlorous acid-mediated inactivation of glyceraldehyde-3-phosphate dehydrogenase andATP generation in human leukocytes as a possible mechanism of ascorbate-mediated immunostimulation. Ann NYAcad Sci 1990; 587:34–48.Google Scholar
  40. 41.
    McSharry C, Wilkinson PC. Cigarette smoking and the antibody response to inhaled antigens. Immunol Today 1986; 7:98.CrossRefGoogle Scholar
  41. 42.
    Ferson M, Edwards A, Lind A, Milton GW, Hersey P. Low natural killer cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 1979; 23:603–609.CrossRefGoogle Scholar
  42. 43.
    Schectman G. Estimating ascorbic acid requirements for cigarette smokers. Ann NY Acad Sci 1993; 686:335–346.CrossRefGoogle Scholar
  43. 44.
    Bridges RB, Chow CK, Rehm SR. Micronutrient status and immune function in smokers. Ann NY Acad Sci 1990; 587:218–231.Google Scholar
  44. 45.
    Pacht ER, Kaseki H, Mohammed JR, Comwell DG, Davis WB. Deficiency of vitamin E in the alveolar fluid of cigarette smokers. J Clin Invest 1986; 77:789–796.CrossRefGoogle Scholar
  45. 46.
    Tribble DL, Guiliano L, Fortmann SP Reduced plasma ascorbic acid concentrations in nonsmokers regularly exposed to enviromnental tobacco smoke. Am J Clin Nutr 1993; 58:886–890.Google Scholar
  46. 47.
    Van Antwerpen VL, Theron AJ, Richards GA, Anderson R. Plasma vitamin C in male smokers. J Smoking-Related Dis 1994; 5:167–170.Google Scholar
  47. 48.
    Van Antwerpen VL, Theron AJ, Myer MS, et al. Cigarette smoke-mediated oxidative stress, phagocytes, vitamin C, vitamin E and tissue injury. Ann NYAcad Sci 1993; 686:53–65.CrossRefGoogle Scholar
  48. 49.
    Pryor WA, Dooley MM. Inactivation of human alpha-1-proteinase inhibitor by cigarette smoke: effect of smoke phase and buffer. Am Rev Resp Dis 1983; 131:941–943.Google Scholar
  49. 50.
    Theron AJ, Anderson R. Investigation of the protective effects of the anti-oxidants ascorbate, cysteine and dapsone on the phagocyte-mediated oxidative inactivation of human alpha-1-protease inhibitor in vitro. Am Rev Respir Dis 1985; 132:1049–1054.Google Scholar
  50. 51.
    Suomalainen K, Sorsa T, Lindy O, Saari H, Konttinen YT, Uitto VJ. Hypochlorous acid activation of human neutrophil and gingival crevicular fluid collagenase can be inhibited by ascorbate. Scand J Dent Res 1991; 99:397–405.Google Scholar
  51. 52.
    Schwartz J, Weiss ST. Relationship between dietary vitamin C and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES 1). Am J Clin Nutr 1994; 59:110–114.Google Scholar
  52. 53.
    Baehner RL, Boxer LA, Ingraham LM, Buetterick C, Haak RA. The influence of vitamin E on human polymorphonuclear cell metabolism and function. Ann NY Acad Sci 1982; 293:237–250.CrossRefGoogle Scholar
  53. 54.
    Richards GA, Theron AJ, Van Rensburg CEJ, et al. Investigation of the effects of oral administration of vitamin E and beta-carotene on the chemiluminescence responses and the frequency of sister chromatid exchanges in circulating leukocytes from cigarette smokers. Am Rev Resp Dis 1990; 142:648–654.Google Scholar
  54. 55.
    Anderson R, Theron AJ, Myer MS, Richards GA, Savage JE. Vitamin E is a potent inhibitor of superoxide generation by neutrophils activated with soluble, but not particulate stimuli of membrane-associated oxidative metabolism. J Nutr Immunol 1992; 1:43–63.Google Scholar
  55. 56.
    Steinbeck MJ, Khan AU, Karnovsky MJ. Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coated with a chemical trap. J Biol Chem 1992; 267:13,425–13,433.Google Scholar
  56. 57.
    Van Antwerpen VL, Theron AJ, Richards GA, Van der Merwe CA, Van der Walt R, Anderson R. Relationship between the plasma levels of beta-carotene and lung functions in cigarette smokers. hnt J Vit Nutr Res 1995; 65:231–235.Google Scholar
  57. 58.
    Van Antwerpen VL, Theron AJ, Richards CA, et al. Vitamin E, pulmonary functions and phagocytemediated oxidative stress in smokers and non-smokers. Free Radic Biol Med 1995; 18:935–941.CrossRefGoogle Scholar
  58. 59.
    Chow CK, Airriess GR, Changchit C. Increased vitamin E content in the lungs of chronic cigarette-smoked rats. Ann NYAcad Sci 1989; 570:425–427.CrossRefGoogle Scholar
  59. 60.
    Elsayed NM. Mobilization of vitamin E to the lung under oxidative stress. Ann NY Acad Sci 1989; 570:439,440.Google Scholar
  60. 61.
    Trout DL. Vitamin C and cardiovascular risk factors. Am J Clin Nutr 1991; 53:322S–325S.Google Scholar
  61. 62.
    Hallfrisch J, Singh VN, Muller DC, Baldwin H, Bannon ME, Andres R. High plasma vitamin C associated with high plasma HDL- and HDL2 cholesterol. Am J Clin Nutr 1994; 60:100–105.Google Scholar
  62. 63.
    Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991; 53:326S–334S.Google Scholar
  63. 64.
    Riemersma RA, Wood DA, Maclntyre CCA, Elton RA, Gey KF, Oliver MF Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 1991; 337:1–5.CrossRefGoogle Scholar
  64. 65.
    Jailal I, Veg GL, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 1990; 82:185–191.CrossRefGoogle Scholar
  65. 66.
    Harats D, Ben-Naim M, Dabach Y, et al. Effect of vitamin C and vitamin E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 1990; 85:47–54.Google Scholar
  66. 67a.
    Salonen JT, Ylä-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339:883–887.CrossRefGoogle Scholar
  67. 67b.
    Fickl H, Van Antwerpen VL, Richards GA, Van der Westhuyzen DR, Davies N, Van der Walt R, Van der Merwe CA, Anderson R. Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamim C in cigarette smokers. Atherosclerosis 1996; 124:75–81.CrossRefGoogle Scholar
  68. 68.
    Packer L. Health effects of nutritional antioxidants. Free Radic Biol Med 1993; 15:685–686.CrossRefGoogle Scholar
  69. 69.
    The Alpha-Tocopherol and Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med 1994; 330:1029–1035.Google Scholar
  70. 70.
    Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. New Engl J Med 1994; 331:141–147.CrossRefGoogle Scholar
  71. 71.
    Theron AJ, Richards GA, Myer MS, et al. Investigation of the relative contributions of cigarette smoking and mineral dust exposure to activation of circulating phagocytes, alterations in plasma concentrations of vitamin C, vitamin E and beta-carotene, and pulmonary dysfunction in South African gold miners. Occ Environ Med 1994; 51:564–567.Google Scholar
  72. 72.
    Richards GA, Terblanche APS, Theron AJ, et al. Health effects of passive smoking in adolescent children. S Afr Med J 1996; 86:143–147.Google Scholar
  73. 73.
    Grimm RH Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer and all-cause mortality. JAMA 1985; 254:1932–1937.CrossRefGoogle Scholar
  74. 74.
    Phillips AN, Neaton JD, Cook DG, Grimm RH, Shaper AG. Leukocyte count and risk of major coronary heart disease events. Am J Epidemiol 1992; 136:59–70.Google Scholar
  75. 75.
    Friedman GD, Selby JV, Quesenberry CP Jr. The leukocyte count: a predictor of hypertension. J Clin Epidemiol 1990; 43:907–911.CrossRefGoogle Scholar
  76. 76.
    Phillips AN, Neaton JD, Cook DG, Grimm RH, Shaper AG. The leukocyte count and risk of lung cancer. Cancer 1992; 69:680–684.CrossRefGoogle Scholar
  77. 77.
    Friedman GD, Fireman BH. The leukocyte count and cancer mortality. Am J Epidemiol 1991; 133:376–380.Google Scholar
  78. 78.
    De Labry LO, Campion EW, Glynn RJ, Vokonas PS. White blood cell count as a predictor of mortality: results over 18 years from the normative aging study. J Clin Epidemiol 1990; 43:153–157.CrossRefGoogle Scholar
  79. 79.
    Van Antwerpen VL, Theron AJ, Richards GA, et al. Plasma levels of beta-carotene are inversely correlated with circulating neutrophil counts in young male cigarette smokers. Inflammation 1995; 19:405–414.CrossRefGoogle Scholar
  80. 80.
    Kallner AB, Hartmann D, Hornig DH. On the requirements of ascorbic acid in man: steady-state turnover and body pool in smokers. Am J Clin Nutr 1981; 34:1347–1355.Google Scholar
  81. 81.
    Frei B, England L, Ames BN. Ascorbic acid is an outstanding anti-oxidant in blood plasma. Proc Natl Acad Sci USA 1989; 86:6377–6381.CrossRefGoogle Scholar
  82. 82.
    Block G. Micronutrients and cancer: time for action? J Natl Cancer Inst (USA) 1993; 85:846–848.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Ronald Anderson

There are no affiliations available

Personalised recommendations